Johnston et al. developed an intra-operative UC-glucose infusion protocol that is well tolerated by patients with pediatric cancers and shows cancer-type-specific metabolic alterations with therapeutical consequences. The development of this procedure and their findings will strongly benefit metabolic analysis of pediatric cancers and design of new therapeutic strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191578 | PMC |
http://dx.doi.org/10.1016/j.medj.2021.03.006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!